trial ReceivesAction designed to evaluate immunogenicity
Typicality: 0.325
Saliency: 0.176

Facets 1
to assess safety 2 purpose
Open triples 2
trial → be designed to evaluate → immunogenicity 5
trial → be designed to assess → immunogenicity 4
Sentiment analysis
negative neutral positive
0.100 0.825 0.075
Other statistics
Raw frequency 9
Normalized frequency 0.176
Modifier score 0.500
Perplexity 65.793